Global Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) Market Report 2021: Increasing Need for CMOs to Cope with Demand for Cell and Gene Therapy Products

News provided by

May 10, 2021, 07:15 ET

DUBLIN, May 10, 2021 /PRNewswire/ -- The "The Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)" report has been added to ResearchAndMarkets.com's offering.

Contract manufacturing is an increasing part of the pharmaceutical business. In cell therapy, this need is magnified because of the demand for cell and gene therapy products.

The report the Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) details the following:

Biopharmaceutical Contract Manufacturing Market

Role
Services Offered
Usage Drivers

Profiles of Companies, Key Players, and Competitors in the Market
COVID-19's Challenges and Opportunities for CMOs
Global and Regional Market Overviews - U.S., Europe, and Other Nations
New Developments and Advancing Technology

Development pipeline
Production Issues
Cost
Logistics

Mergers and Acquisitions

There are many companies in this market, and the analyst profiles a select group of companies that are representative of the market or handle a large volume.

These companies include:

AGC Biologics
Ajinomoto Bio-Pharma Services
Anemocyte
Astellas
BioNTech IMFS
Boehringer Ingelheim BioXcellence
Bristol Myers Squibb
Catalent
Cognate BioServices/CRL
Cytiva
Cytovance Biologics
Fresenius Kabi Product Partnering
FUJIFILM Cellular Dynamics
FUJIFILM Diosynth Biotechnologies
Grifols
Lonza
Millipore Sigma/BioReliance
Minaris Regenerative Medicine
Novartis
Oxford Biomedica
Patheon/Thermo Fisher Scientific
Pfizer CentreOne
Porton Biologics
Syngene International
Takara Bio
Takeda
The Center for Breakthrough Medicines
Vibalogics
WuXi AppTec
WuXi Biologics
Yposkesi

Key Topics Covered:

Chapter 1: Executive Summary

Overview

Scope and Methodology

Covid 19

Market Overview and Potential

Cell and Gene Therapy Market
BCMO Market
Cell and Gene Therapy BCMO Market

Chapter 2: Introduction to Cell and Gene Therapy

Introduction

Cell Therapy
Gene Therapy
Viral Vector System and New Developments
Non-viral Systems for Transporting Genes
End Users
Hospitals
Research Institutes
Wound Care Centers
Cancer Centers

Chapter 3: Cell and Gene Therapy Industry - Product Pipeline, Production & Key Players

Overview

Regulatory Pathway
Priority Review
Accelerated Approval
Fast Track
Breakthrough Therapy
Orphan Drug
Individualized Gene Therapy Approval Process
Development Pipeline
Production Issues
Manufacturing Process for CAR-T
Advancements and Barriers in Manufacturing Processes

Cost
Timing
Logistics
Capacity Shortfall
In-House Manufacturing
Staffing

Key Players
Mergers and Acquisitions

Chapter 4: Cell and Gene Therapy Markets

Overview

Global Cell and Gene Therapy Markets
Regional Market Overview
United States
Europe/European Union
Other Countries
Leading Competitors

Chapter 5: Biopharma Contract Manufacturing

Introduction

The Role of BCMOs
Services Offered by BCMOs
Usage Drivers
Growth Constraints

Chapter 6: Biopharma Contract Manufacturing Markets

Overview

Global BCMO Markets
Regional Market Overview
United States
Europe/European Union
Other Countries
Leading Competitors

Chapter 7: Cell & Gene Therapy Contract Manufacturing

Introduction

Advancing Technology
Dearth of Intellectual Capital
cGMP Compliance
Quality by Design

Chapter 8: The Market for Cell & Gene Therapy Contract Manufacturing

Overview

Global Cell and Gene Therapy BCMO Market
Market by Therapeutic Indication
Market by Method
Market by Manufacturing Stage
Market by Global Region
Leading Competitors
Mergers and Acquisitions

Chapter 9: Key Players in the Cell & Gene Therapy CMO Market

For more information about this report visit https://www.researchandmarkets.com/r/jih3bw

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets